Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: An in vivo imaging and migration study

Joshua Wood, Dai Jung Chung, Shin Ae Park, Allison Zwingenberger, Christopher M. Reilly, Irene Ly, Naomi J. Walker, William Vernau, Kei Hayashi, Erik R Wisner, Matthew S. Cannon, Philip H Kass, Simon R Cherry, Dori L Borjesson, Paul Russell, Christopher J Murphy

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Purpose: Immune-mediated diseases affect millions of people worldwide with an economic impact measured in the billions of dollars. Mesenchymal stem cells (MSCs) are being investigated in the treatment of certain immune mediated diseases, but their application in the treatment of the majority of these disorders remains largely unexplored. Keratoconjunctivitis sicca can occur as a result of progressive immune-mediated destruction of lacrimal tissue in dogs and humans, and immune-mediated joint disease is common to both species. In dogs, allogeneic MSC engraftment and migration have yet to be investigated in vivo in the context of repeated injections. Methods: With these aims in mind, the engraftment of allogeneic canine MSCs after an injection into the periocular and intra-articular regions was followed in vivo using magnetic resonance and fluorescent imaging. Results: The cells were shown to be resident near the site of the injection for a minimum of 2 weeks. Analysis of 61 tissues demonstrated preferential migration and subsequent engraftment of MSCs in the thymus as well as the gastrointestinal tract. These results also detail a novel in vivo imaging technique and demonstrate the differential spatial distribution of MSCs after migration away from the sites of local delivery. Conclusion: The active engraftment of the MSCs in combination with their previously documented immunomodulatory capabilities suggests the potential for therapeutic benefit in using MSCs for the treatment of periocular and joint diseases with immune involvement.

Original languageEnglish (US)
Pages (from-to)307-317
Number of pages11
JournalJournal of Ocular Pharmacology and Therapeutics
Volume28
Issue number3
DOIs
StatePublished - Jun 1 2012

Fingerprint

Intra-Articular Injections
Mesenchymal Stromal Cells
Canidae
Joint Diseases
Immune System Diseases
Cell Movement
Keratoconjunctivitis Sicca
Dogs
Intraocular Injections
Injections
Therapeutics
Tears
Thymus Gland
Gastrointestinal Tract
Joints
Economics
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Ophthalmology
  • Pharmacology

Cite this

Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells : An in vivo imaging and migration study. / Wood, Joshua; Chung, Dai Jung; Park, Shin Ae; Zwingenberger, Allison; Reilly, Christopher M.; Ly, Irene; Walker, Naomi J.; Vernau, William; Hayashi, Kei; Wisner, Erik R; Cannon, Matthew S.; Kass, Philip H; Cherry, Simon R; Borjesson, Dori L; Russell, Paul; Murphy, Christopher J.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 28, No. 3, 01.06.2012, p. 307-317.

Research output: Contribution to journalArticle

@article{1eb3ef01eb4e4a78a0f23d814c699ab9,
title = "Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: An in vivo imaging and migration study",
abstract = "Purpose: Immune-mediated diseases affect millions of people worldwide with an economic impact measured in the billions of dollars. Mesenchymal stem cells (MSCs) are being investigated in the treatment of certain immune mediated diseases, but their application in the treatment of the majority of these disorders remains largely unexplored. Keratoconjunctivitis sicca can occur as a result of progressive immune-mediated destruction of lacrimal tissue in dogs and humans, and immune-mediated joint disease is common to both species. In dogs, allogeneic MSC engraftment and migration have yet to be investigated in vivo in the context of repeated injections. Methods: With these aims in mind, the engraftment of allogeneic canine MSCs after an injection into the periocular and intra-articular regions was followed in vivo using magnetic resonance and fluorescent imaging. Results: The cells were shown to be resident near the site of the injection for a minimum of 2 weeks. Analysis of 61 tissues demonstrated preferential migration and subsequent engraftment of MSCs in the thymus as well as the gastrointestinal tract. These results also detail a novel in vivo imaging technique and demonstrate the differential spatial distribution of MSCs after migration away from the sites of local delivery. Conclusion: The active engraftment of the MSCs in combination with their previously documented immunomodulatory capabilities suggests the potential for therapeutic benefit in using MSCs for the treatment of periocular and joint diseases with immune involvement.",
author = "Joshua Wood and Chung, {Dai Jung} and Park, {Shin Ae} and Allison Zwingenberger and Reilly, {Christopher M.} and Irene Ly and Walker, {Naomi J.} and William Vernau and Kei Hayashi and Wisner, {Erik R} and Cannon, {Matthew S.} and Kass, {Philip H} and Cherry, {Simon R} and Borjesson, {Dori L} and Paul Russell and Murphy, {Christopher J}",
year = "2012",
month = "6",
day = "1",
doi = "10.1089/jop.2011.0166",
language = "English (US)",
volume = "28",
pages = "307--317",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells

T2 - An in vivo imaging and migration study

AU - Wood, Joshua

AU - Chung, Dai Jung

AU - Park, Shin Ae

AU - Zwingenberger, Allison

AU - Reilly, Christopher M.

AU - Ly, Irene

AU - Walker, Naomi J.

AU - Vernau, William

AU - Hayashi, Kei

AU - Wisner, Erik R

AU - Cannon, Matthew S.

AU - Kass, Philip H

AU - Cherry, Simon R

AU - Borjesson, Dori L

AU - Russell, Paul

AU - Murphy, Christopher J

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Purpose: Immune-mediated diseases affect millions of people worldwide with an economic impact measured in the billions of dollars. Mesenchymal stem cells (MSCs) are being investigated in the treatment of certain immune mediated diseases, but their application in the treatment of the majority of these disorders remains largely unexplored. Keratoconjunctivitis sicca can occur as a result of progressive immune-mediated destruction of lacrimal tissue in dogs and humans, and immune-mediated joint disease is common to both species. In dogs, allogeneic MSC engraftment and migration have yet to be investigated in vivo in the context of repeated injections. Methods: With these aims in mind, the engraftment of allogeneic canine MSCs after an injection into the periocular and intra-articular regions was followed in vivo using magnetic resonance and fluorescent imaging. Results: The cells were shown to be resident near the site of the injection for a minimum of 2 weeks. Analysis of 61 tissues demonstrated preferential migration and subsequent engraftment of MSCs in the thymus as well as the gastrointestinal tract. These results also detail a novel in vivo imaging technique and demonstrate the differential spatial distribution of MSCs after migration away from the sites of local delivery. Conclusion: The active engraftment of the MSCs in combination with their previously documented immunomodulatory capabilities suggests the potential for therapeutic benefit in using MSCs for the treatment of periocular and joint diseases with immune involvement.

AB - Purpose: Immune-mediated diseases affect millions of people worldwide with an economic impact measured in the billions of dollars. Mesenchymal stem cells (MSCs) are being investigated in the treatment of certain immune mediated diseases, but their application in the treatment of the majority of these disorders remains largely unexplored. Keratoconjunctivitis sicca can occur as a result of progressive immune-mediated destruction of lacrimal tissue in dogs and humans, and immune-mediated joint disease is common to both species. In dogs, allogeneic MSC engraftment and migration have yet to be investigated in vivo in the context of repeated injections. Methods: With these aims in mind, the engraftment of allogeneic canine MSCs after an injection into the periocular and intra-articular regions was followed in vivo using magnetic resonance and fluorescent imaging. Results: The cells were shown to be resident near the site of the injection for a minimum of 2 weeks. Analysis of 61 tissues demonstrated preferential migration and subsequent engraftment of MSCs in the thymus as well as the gastrointestinal tract. These results also detail a novel in vivo imaging technique and demonstrate the differential spatial distribution of MSCs after migration away from the sites of local delivery. Conclusion: The active engraftment of the MSCs in combination with their previously documented immunomodulatory capabilities suggests the potential for therapeutic benefit in using MSCs for the treatment of periocular and joint diseases with immune involvement.

UR - http://www.scopus.com/inward/record.url?scp=84862212113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862212113&partnerID=8YFLogxK

U2 - 10.1089/jop.2011.0166

DO - 10.1089/jop.2011.0166

M3 - Article

C2 - 22175793

AN - SCOPUS:84862212113

VL - 28

SP - 307

EP - 317

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 3

ER -